The Impact of Medical Insurance Coverage of Imatinib and Molecular Monitoring Frequency on Outcomes in Treatment of Chronic Myeloid Leukaemia (CML)- A Real World Evidence in China
Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.312
https://www.valueinhealthjournal.com/article/S1098-3015(16)30892-0/fulltext
Title :
The Impact of Medical Insurance Coverage of Imatinib and Molecular Monitoring Frequency on Outcomes in Treatment of Chronic Myeloid Leukaemia (CML)- A Real World Evidence in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30892-0&doi=10.1016/j.jval.2016.08.312
First page :
A880
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2686